![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Chapter and Conference Paper
A combination chemotherapy with Ifosfamide (I), Cisplatin (P) and Etoposide (E) for advanced non-small cell lung cancer (NSCLC)
The role of combination chemotherapy in the treatment of NSCLC remains controversial. One of the most widely used conbinations is PE which yielded a 32 % response rate in 682 patients [1]. Efforts to improve t...
-
Chapter and Conference Paper
Induction chemotherapy with Cisplatin (P), 5-Fluorouracil (FU) and Folinic Acid (FA) in locally advanced head and neck cancer
It has been observed that a synergism exists between Cisplatin (P) and 5-Fluorouracil (FU) when these agents are jointly administered in continuous perfusion.
-
Chapter and Conference Paper
Neo-Adjuvant chemotherapy with Cisplatin and 5-Fluorouracil, both in continuous 96 hours perfusion, in the multidisciplinary treatment of locally advanced head and neck cancer
The introduction of induction chemotherapy in the treatment of locally advanced head and neck cancer with protocols based on Cisplatin has increased the number of patients in which complete control of the dise...